Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7124784> ?p ?o }
Showing triples 1 to 21 of
21
with 100 triples per page.
- Q7124784 subject Q8760151.
- Q7124784 subject Q8794510.
- Q7124784 abstract "PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system on nociceptors to treat pain. The company's strategic focus on peripheral rather than central acting therapeutics is an attempt to avoid the known side-effects of existing central acting agents. The primary molecular targets addressed by PainCeptor are members of the ASIC ion channel family and nerve growth factor (NGF) and NGF receptors. Though PainCeptor refers to itself as a biopharmaceutical company on its website, its two primary publicly reported drug discovery projects aim to deliver small molecule therapeutics.".
- Q7124784 wikiPageExternalLink www.painceptor.com.
- Q7124784 wikiPageWikiLink Q1418791.
- Q7124784 wikiPageWikiLink Q14873931.
- Q7124784 wikiPageWikiLink Q1589009.
- Q7124784 wikiPageWikiLink Q16.
- Q7124784 wikiPageWikiLink Q169953.
- Q7124784 wikiPageWikiLink Q412542.
- Q7124784 wikiPageWikiLink Q4222244.
- Q7124784 wikiPageWikiLink Q47273.
- Q7124784 wikiPageWikiLink Q5308941.
- Q7124784 wikiPageWikiLink Q679692.
- Q7124784 wikiPageWikiLink Q81938.
- Q7124784 wikiPageWikiLink Q8386.
- Q7124784 wikiPageWikiLink Q8760151.
- Q7124784 wikiPageWikiLink Q8794510.
- Q7124784 wikiPageWikiLink Q904407.
- Q7124784 comment "PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system on nociceptors to treat pain. The company's strategic focus on peripheral rather than central acting therapeutics is an attempt to avoid the known side-effects of existing central acting agents. The primary molecular targets addressed by PainCeptor are members of the ASIC ion channel family and nerve growth factor (NGF) and NGF receptors.".
- Q7124784 label "PainCeptor Pharma".